Skip to main content
Clinical Trials/NCT03862183
NCT03862183UnknownNot Applicable

Survey on BP, Lipids and Cardiovascular Risks in the Outpatient Hypertensives and Continuing Medical Education Program

Huashan Hospital1 site in 1 country21,000 target enrollmentStarted: July 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
21,000
Locations
1
Primary Endpoint
rate of blood pressure goal achievement

Study Overview

Brief Summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.
  • Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.
  • Voluntary participation.

Exclusion Criteria

  • Patients aged< 18 years old.
  • Patients without a definite diagnosis of hypertension(for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension).
  • Patients with a definite diagnosis of secondary hypertension.
  • Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.
  • Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.
  • Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.
  • Patients have once participated in this research during this study cycle(to avoid repeated participation).

Outcomes

Primary Outcomes

rate of blood pressure goal achievement

Time Frame: 2017-2020

systolic blood pressure\<140mmHg and diastolic blood pressure\<90mmHg

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yong Li

associate chief of the cardiology department

Huashan Hospital

Study Sites (1)

Loading locations...

Similar Trials

Hospital-level Variation in the Management... | Clinical Trial